Clare O. Hasken, MD
If the disparate experiences of clinicians across the country are any indication, then the use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) may be a viable option in pregnant patients with COVID-19–related acute respiratory distress syndrome (ARDS).
Nevertheless, the therapeutic approach did not always prove successful in these various cases, leading clinicians to stress the importance of careful patient selection, stringent usage guidelines, and